MedTech Sustainability: A Blueprint for Sector Innovation
In 2025, Mölnlycke Health Care demonstrated how sustainability leadership and business growth need not be mutually exclusive. The 176-year-old MedTech specialist achieved 4% organic sales growth whilst simultaneously advancing ambitious environmental targets across its global operations in more than 100 countries.
For C-suite executives grappling with the dual imperatives of operational performance and climate action, Mölnlycke's approach offers a compelling case study. The company has integrated sustainability into every dimension of its business model, from manufacturing and supply chain design to product innovation and digital transformation, positioning environmental stewardship as a driver of competitive advantage rather than a compliance burden.
The strategic challenge facing healthcare leaders is particularly acute. Global health systems are under unprecedented financial and operational pressure, yet the sector remains a significant contributor to carbon emissions. Mölnlycke's ability to navigate these tensions through its WeCare sustainability roadmap could provide valuable insights for organisations seeking to align clinical excellence with planetary health.
Delivering on science-based climate commitments
Mölnlycke's sustainability credentials gained external validation in 2025 when the Science Based Targets initiative (SBTi) approved its long-term net zero greenhouse gas emission targets. This milestone represents more than symbolic achievement; it signals that the company's decarbonisation pathway aligns with climate science requirements to limit global warming to 1.5C.
The organisation has already achieved a 52% reduction in Scope 1 and 2 emissions compared to its 2021 baseline, demonstrating substantial progress towards its interim targets. All manufacturing sites now operate on 100% renewable electricity, whilst the company's new LEED Platinum-certified global headquarters in Gothenburg exemplifies how built environment decisions can support broader sustainability objectives.
"Today's world is shifting faster and more unpredictably than many of us have experienced before," says Zlatko Rihter, Chief Executive Officer. "This makes focused execution more critical than ever. We succeed by staying close to our customers, making selective and disciplined choices and acting with immediate clarity and long-term commitment."
For Sustainability Directors and Chief Executives, these achievements underscore the importance of establishing measurable, externally verified targets that connect corporate strategy to global climate frameworks. The SBTi validation process requires rigorous evidence of emission reduction pathways, offering stakeholders confidence in stated commitments.
Sustainability, procurement and supply chain leaders wonât want to miss Sustainability LIVE: The US Summit, taking place at Navy Pier, Chicago, on April 21â22.
Co-located with Procurement & Supply Chain LIVE, the event unites senior decision-makers at a time when supply chains, sustainability and business performance are more interdependent than ever.
Secure your place now for The US Summit â group booking discounts available.
Advancing circular economy models
Beyond emission reductions, Mölnlycke is exploring how circular economy principles could reshape MedTech manufacturing. The company concluded a closed-loop recycling pilot in 2025 that chemically recycled post-consumer waste from operating rooms to produce new surgical drapes, demonstrating technical feasibility for materials recovery in clinical settings.
This initiative addresses a significant sustainability challenge within healthcare, where infection control requirements have traditionally necessitated single-use products with limited end-of-life options. By proving that post-consumer medical textiles can be recovered and reintegrated into manufacturing, Mölnlycke is opening pathways for waste reduction across the sector.
In a move that could accelerate industry-wide progress, the company donated a patient risk assessment patent to an open-access platform. This decision prioritises collective sustainability advancement over proprietary advantage, reflecting recognition that systemic healthcare challenges require collaborative solutions.
"Our corporate goals are aligned with the United Nations Sustainable Development Goals (SDGs) most relevant to Mölnlycke," according to the company's annual report. The strategic alignment with SDG frameworks provides clarity on priority areas whilst enabling progress measurement against globally recognised benchmarks.
Integrating sustainability with operational resilience
Mölnlycke's €115m (US$134.5m) expansion of wound care manufacturing capacity in Brunswick, Maine, and establishment of its first wound care manufacturing site in Changshu, China, illustrate how sustainability considerations are being integrated into supply chain decisions. The company also launched ProcedurePak tray assembly operations in Saudi Arabia and Thailand during 2025.
These localisation investments serve multiple strategic purposes. They enhance supply chain resilience against geopolitical volatility and trade restrictions whilst reducing transportation-related emissions through proximity to end markets. For healthcare organisations serving diverse regions, this approach demonstrates how operational efficiency and environmental performance can be simultaneously optimised.
The company's digital transformation initiatives further support sustainability objectives. Implementation of SAP S/4 HANA, a cloud-based ERP platform handling more than 500,000 daily transactions, enables data-driven decision-making that could improve resource efficiency. Meanwhile, approximately 1,800 employees participated in "AI Power Hours" to explore responsible clinical applications of artificial intelligence, building organisational capacity for technology-enabled sustainability improvements.
Mölnlycke's Operating Room Solutions segment launched the "2025 Non-Value Report," surveying more than 200 nurses to identify procedural bottlenecks. In Wound Care, the launch of Mepilex Up in Europe, Middle East and Africa (EMEA) and Canada provided advanced leg ulcer management, whilst the "Wound Care for All" programme introduced the Skin Tone I.D. tool to support inclusive skin assessments. The Gloves segment introduced a tenfold stricter endotoxin standard for its Biogel Tech gloves, enhancing safety for aseptic operations.
For senior executives navigating sustainability transformation, Mölnlycke's integrated approach demonstrates how environmental commitments can be embedded across innovation pipelines, operational infrastructure and workforce development, creating a comprehensive framework for sustainable business leadership in the healthcare sector.
